Panelists discuss how current risk stratification systems, particularly the European Leukemia Net 2022 classification for intensive therapy and the 2024 classification for lower intensity treatments, ...
Correspondence to Dr John E Kuhn, Chief of Shoulder Surgery, Vanderbilt University Medical Center, Vanderbilt Sports Medicine, 3200 MCE South Tower, 1215 21st Avenue South, Nashville, TN 37232, USA; j ...
Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279 Consecutive patients with head and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results